No Data
IPO Roundup: Pershing Square, Actuate Therapeutics and More
Horizon Kinetics Active ETF Webinar Series
Health products company “Qianzhi Biotechnology” plans to go public in the US under the cover of SPAC
Qianzhi Group Holding (Cayman) Limited, the holding company of Shenzhen Qianzhi Biotechnology Co., Ltd., Shenzhen Qianzhi Biotechnology Co., Ltd. from Shenzhen, Guangdong, signed a merger agreement with SPAC (US special purpose acquisition company) Bowen Acquisition Corp (BOWN) to be listed on the US NASDAQ through a backshell SPAC.
Bowen Acquisition Enters Into Merger Agreement With Shenzhen Qianzhi Biotech Company